ShareCast News for Cello Group (CLL)
Wed, 14th Mar 2012 15:32
John Worby, Group Finance Director of Genus, the FTSE 250 animal genetics firm, has sold 43,000 shares, half of the amount he vested earlier this month.
Worby sold 43,261 shares at 1,318.41p each for a total of £570,357. The sale was made further to the vesting of 86,523 conditional nil-cost share options on March 5th under the company's performance share plan.
The remaining 43,262 share options that vested under the plan have been retained by Worby.
Towards the end of last month the firm reported strong growth in sales volumes in Asia has seen animal genetics firm Genus increase revenue by almost a 10th in the first half of its financial year.
Furthermore, after reviewing its dividend policy last year, the firm has decided to start paying an interim dividend for the first time this year. The board has approved an interim dividend of 4.5p per share payable on March 30th.
The stock has rocketed in the past past year, rising almost 44%, equivalent to 404p. The share price is up 0.84%, or 11p over the past week.
Top Director Buys
Capital Shopping Centres Group (CSCG)
Director name: Mr John Whittaker
Amount purchased: 300,000 @ 347.24p
Value: £1,041,720
Capital Shopping Centres Group (CSCG)
Director name: Mr John Whittaker
Amount purchased: 300,000 @ 344.55p
Value: £1,033,650
FBD Holdings (FBH)
Director name: Mr Andrew Langford
Amount purchased: 6,818 @ € 9.03
Value: € 61,567
Cello Group (CLL)
Director name: Mr Mark Scott
Amount purchased: 60,500 @ 41.00p
Value: £24,805
Marks & Spencer Group (MKS)
Director name: Ms Miranda Curtis
Amount purchased: 5,500 @ 367.50p
Value: £20,212
BG Group (BG.)
Director name: Mr Caio Koch-Weser
Amount purchased: 1,000 @ 1,533.14p
Value: £15,331
BG Group (BG.)
Director name: Mr Caio Koch-Weser
Amount purchased: 700 @ 1,535.23p
Value: £10,747
Top Director Sells
Rolls-Royce Holdings (RR.)
Director name: Mr Mike Terrett
Amount sold: 287,997 @ 818.25p
Value: £2,356,535
Barclays (BARC)
Director name: Mr Chris Lucas
Amount sold: 613,536 @ 239.88p
Value: £1,471,750
Rolls-Royce Holdings (RR.)
Director name: Mr Colin P Smith
Amount sold: 175,690 @ 818.25p
Value: £1,437,583
Rolls-Royce Holdings (RR.)
Director name: Mr James M Guyette
Amount sold: 113,484 @ 818.25p
Value: £928,583
Genus (GNS)
Director name: Mr John Worby
Amount sold: 43,261 @ 1,318.41p
Value: £570,357
Sage Group (SGE)
Director name: Mr Guy Berruyer
Amount sold: 113,925 @ 297.97p
Value: £339,462
Sage Group (SGE)
Director name: Mr Guy Berruyer
Amount sold: 105,026 @ 300.00p
Value: £315,078
Sage Group (SGE)
Director name: Mr David Clayton
Amount sold: 72,958 @ 297.97p
Value: £217,393
Sage Group (SGE)
Director name: Mr Paul Harrison
Amount sold: 72,660 @ 297.97p
Value: £216,505
Rolls-Royce Holdings (RR.)
Director name: Mr Mark Morris
Amount sold: 24,846 @ 818.25p
Value: £203,302
Marketing firm Cello said strong trading has continued so far this year, driven by its health division and a recovery at its consumer unit, and expects half year results higher than last year.
[14 May '13]African Barrick Gold: Deutsche Bank cuts target price from 230p to 173p, while its hold recommendation is reiterated.
[17 Apr '13]Marketing firm Cello Group said after a challenging first half, it recovered strongly in the second half, as it looks forward to further progress in the current year.
[13 Mar '13]Marketing firm Cello Group reported that 2012 trading had been in line with expectations and it was 'in good stead' as it went into the new year.
[28 Jan '13]Energy and sustainability consultancy AEA Technology has warned trading conditions remain challenging, but said good progress is being made in the implementation of its business plan. The company is able to consider all strategic options to realise value after it recently secured additional short-term funding. The firm said that while it is having on-going and constructive discussions with a number of interested parties, it does not, as previously announced, envisage that the
[19 Sep '12]This round-up also covers: Pennant International Group, Active Energy, ValiRx, Angel Biotechnology, and Motive Televsion.
[15 May '12]A round-up of the biggest director deals today so far.
[14 Mar '12]Market insight and strategic marketing combo Cello has whacked up its full year dividend by a fifth, despite one off costs turning earnings per share negative.
[13 Mar '12]